PRT3789

News alerts, weekly reports and conference planners

Company:

Prelude Therap

Drug class:

SMARCA2 degrader

Related drugs:

‹

›

SMARCA4 deletion	Non Small Cell Lung Cancer	SMARCA4 deletion	Non Small Cell Lung Cancer	PRT3789 Sensitive: D – Preclinical PRT3789 Sensitive : D	PRT3789 Sensitive: D – Preclinical PRT3789 Sensitive : D
SMARCA4 deletion	Lung Cancer	SMARCA4 deletion	Lung Cancer	PRT1419 + PRT3789 Sensitive: D – Preclinical PRT1419 + PRT3789 Sensitive : D	PRT1419 + PRT3789 Sensitive: D – Preclinical PRT1419 + PRT3789 Sensitive : D

Associations
(2)